User profiles for Marc G Romney
 | Marc RomneyClinical Professor, University of British Columbia Verified email at providencehealth.bc.ca Cited by 2416 |
Reduced magnitude and durability of humoral immune responses to COVID-19 mRNA vaccines among older adults
…, R Pantophlet, M Niikura, MG Romney… - The Journal of …, 2022 - academic.oup.com
Background The magnitude and durability of immune responses to coronavirus disease
2019 (COVID-19) mRNA vaccines remain incompletely characterized in the elderly. Methods …
2019 (COVID-19) mRNA vaccines remain incompletely characterized in the elderly. Methods …
[HTML][HTML] Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy
Humoral responses to COVID-19 vaccines in people living with HIV (PLWH) remain
incompletely characterized. We measured circulating antibodies against the SARS-CoV-2 spike …
incompletely characterized. We measured circulating antibodies against the SARS-CoV-2 spike …
Suboptimal biological sampling as a probable cause of false-negative COVID-19 diagnostic test results
…, JSG Montaner, V Leung, MG Romney… - The Journal of …, 2020 - academic.oup.com
False-negative severe acute respiratory syndrome coronavirus 2 test results can negatively
impact the clinical and public health response to coronavirus disease 2019 (COVID-19). We …
impact the clinical and public health response to coronavirus disease 2019 (COVID-19). We …
[HTML][HTML] Bedbugs as vectors for drug-resistant bacteria
CF Lowe, MG Romney - Emerging infectious diseases, 2011 - ncbi.nlm.nih.gov
To the Editor: Over the past 10 years in North America and western Europe, a resurgence of
bedbugs (Cimex lectularius) has occurred (1). Although the basis for this resurgence is …
bedbugs (Cimex lectularius) has occurred (1). Although the basis for this resurgence is …
Older adults mount less durable humoral responses to two doses of COVID-19 mRNA vaccine but strong initial responses to a third dose
Background Third coronavirus disease 2019 (COVID-19) vaccine doses are broadly
recommended, but immunogenicity data remain limited, particularly in older adults. Methods We …
recommended, but immunogenicity data remain limited, particularly in older adults. Methods We …
[HTML][HTML] Rapid detection of SARS-CoV-2 variants of concern, including B. 1.1. 28/P. 1, British Columbia, Canada
To screen all severe acute respiratory syndrome coronavirus 2–positive samples in Vancouver,
British Columbia, Canada, and determine whether they represented variants of concern, …
British Columbia, Canada, and determine whether they represented variants of concern, …
Incidence and Costs of Clostridium difficile Infections in Canada
…, V Leung, R Lawrence, MG Romney - Open forum …, 2015 - academic.oup.com
Background. Limited data are available on direct medical costs and lost productivity due to
Clostridium difficile infection (CDI) in Canada. Methods. We developed an economic model to …
Clostridium difficile infection (CDI) in Canada. Methods. We developed an economic model to …
[HTML][HTML] People with HIV receiving suppressive antiretroviral therapy show typical antibody durability after dual COVID-19 vaccination, and strong third dose …
…, N Prystajecky, CF Lowe, R Pantophlet, MG Romney… - medRxiv, 2022 - ncbi.nlm.nih.gov
Background: Longer-term humoral responses to two-dose COVID-19 vaccines remain
incompletely characterized in people living with HIV (PLWH), as do initial responses to a third …
incompletely characterized in people living with HIV (PLWH), as do initial responses to a third …
[HTML][HTML] Rapid increase in SARS-CoV-2 P. 1 lineage leading to codominance with B. 1.1. 7 lineage, British Columbia, Canada, January–April 2021
…, A Wilmer, J Galbraith, MG Romney… - Emerging infectious …, 2021 - ncbi.nlm.nih.gov
Several severe acute respiratory syndrome coronavirus 2 variants of concern (VOCs) emerged
in late 2020; lineage B. 1.1. 7 initially dominated globally. However, lineages B. 1.351 …
in late 2020; lineage B. 1.1. 7 initially dominated globally. However, lineages B. 1.351 …
[HTML][HTML] Practical challenges to the clinical implementation of saliva for SARS-CoV-2 detection
Due to global shortages of flocked nasopharyngeal swabs and appropriate viral transport
media during the COVID-19 pandemic, alternate diagnostic specimens for SARS-CoV-2 …
media during the COVID-19 pandemic, alternate diagnostic specimens for SARS-CoV-2 …